Omontys

View On IPO.GOV.UK

Dead

on 7 Feb 2012

Last Applicant/ Owned by

Affymax Pharma Limited

The Broadgate Tower, 3rd Floor, 20 Primrose Street, London

, , EC2A 2RS

Serial Number

UK00002609451 filed on 7^th Feb 2012

Registration Number

UK00002609451 registered on
11^th May 2012

Correspondent Information

Kilburn & Strode LLP

Lacon London, 84 Theobalds Road, Holborn

London,

WC1X 8NL

Omontys

pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer. anaemia, ischemia, myocardial infarct Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer. anaemia, ischemia, myocardial infarction, congestive heart failure , renal failure; anoxia-induced cellular degeneration; hypoxia-induced cellular degeneration and stroke.

Mark Details

Serial Number

UK00002609451

Mark Type

Figurative

Kind of mark

Individual

Omontys

Classification Information

Class [5]Pharmaceutical Products

Mark Details

Serial Number

Mark Type

Kind of mark

Class [5]
Pharmaceutical Products